Grunberger Diabetes Institute logo
Phone: (248) 335-7740
Fax: (248) 338-7979
Send Email
FDA OKs Dapagliflozin to Reduce HF Hospitalization in Diabetes
GDI Staff

GDI Staff

Oct 23, 2019

FDA OKs Dapagliflozin to Reduce HF Hospitalization in Diabetes

Click here for the article posted by Lisa Nainggolan on Medscape.

GDI Staff

GDI Staff

Leave a Reply

Related Posts

Categories